{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:22:32Z","timestamp":1770913352951,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.diagmicrobio.2025.117206","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T17:01:20Z","timestamp":1764003680000},"page":"117206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic effect of ceftazidime-avibactam and aztreonam combination against carbapenem resistant Klebsiella spp., E.coli and Pseudomonas spp"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1247-1391","authenticated-orcid":false,"given":"Jannatul Nazerin","family":"Rubaiat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourav","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Abu","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaheda","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10325","key":"10.1016\/j.diagmicrobio.2025.117206_bib0001","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0002","first-page":"1","article-title":"Antimicrobial resistance: tackling a crisis for the health and wealth of nations","author":"O\u2019Neill","year":"2014","journal-title":"Rev Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0003","doi-asserted-by":"crossref","unstructured":"Safain K.S., Bhuyan G.S., Tasnim S., Hasib S.H. Situation of antibiotic resistance in Bangladesh and its association with. BioRxiv. 2020.","DOI":"10.1101\/2020.04.06.027391"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01243-16","article-title":"Carbapenem-resistant pseudomonas aeruginosa bacteremia: risk factors for mortality and microbiologic treatment failure","volume":"61","author":"Buehrle","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0005","first-page":"1","article-title":"Prevalence and molecular epidemiology of carbapenem resistance in Asia: a systematic review and meta-analysis","author":"Jayathilaka","year":"2024","journal-title":"Res Sq [Internet]"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0006","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3329\/bjms.v21i1.56341","article-title":"Prevalence of imipenem resistant gram-negative bacteria in a tertiary care hospital of Dhaka, Bangladesh","volume":"21","author":"Ferdous","year":"2022","journal-title":"Bangladesh J Med Sci [Internet]"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-015-0061-0","article-title":"Mechanisms of antimicrobial resistance in gram-negative bacilli","volume":"5","author":"Rupp\u00e9","year":"2015","journal-title":"Ann Intensive Care"},{"issue":"Suppl 7","key":"10.1016\/j.diagmicrobio.2025.117206_bib0008","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1093\/cid\/ciz824","article-title":"Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria","volume":"69","author":"Nordmann","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2025.117206_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02000-20","article-title":"Epidemiology of carbapenem resistance determinants identified in meropenem-nonsusceptible enterobacterales collected as part of a global surveillance program, 2012 to 2017","volume":"65","author":"Kazmierczak","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.117206_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1469-0691.2002.00401.x","article-title":"Emerging carbapenemases in gram-negative aerobes","volume":"8","author":"Nordmann","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.117206_bib0011","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1128\/JCM.00130-09","article-title":"Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae","volume":"47","author":"Pasteran","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"18","key":"10.1016\/j.diagmicrobio.2025.117206_bib0012","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","article-title":"\u03b2-lactamases and \u03b2-lactamase inhibitors in the 21st century","volume":"431","author":"Tooke","year":"2019","journal-title":"J Mol Biol [Internet]"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.117206_bib0013","first-page":"1","article-title":"NDM metallo-\u03b2-lactamases and their bacterial producers in health care settings","volume":"32","author":"Wu","year":"2019","journal-title":"Clin Microbiol Rev [Internet]"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-017-1012-8","article-title":"Genetics and worldwide spread of New Delhi metallo-\u03b2-lactamase (NDM): a threat to public health","volume":"17","author":"Khan","year":"2017","journal-title":"BMC Microbiol"},{"issue":"15","key":"10.1016\/j.diagmicrobio.2025.117206_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AEM.00793-17","article-title":"Environmental spread of New Delhi metallo-N\/L-lactamase-1-producing multidrug-resistant bacteria in Dhaka, Bangladesh","volume":"83","author":"Islam","year":"2017","journal-title":"Appl Env Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.117206_bib0016","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s10096-012-1601-2","article-title":"Emergence of multidrug-resistant NDM-1-producing gram-negative bacteria in Bangladesh","volume":"31","author":"Islam","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3329\/imcj.v4i1.5932","article-title":"Simple screening tests for the detection of metallo- \u03b2 - lactamase (MBL) production In clinical isolates of Pseudomonas and Acinetobacter","volume":"4","author":"Anwar","year":"2010","journal-title":"Ibrahim Med Coll J"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.117206_bib0018","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s40121-021-00506-7","article-title":"Clinical and microbiological outcomes of ceftazidime-avibactam treatment in adults with gram-negative bacteremia: a subset analysis from the phase 3 Clinical trial program","volume":"10","author":"Mazuski","year":"2021","journal-title":"Infect Dis Ther [Internet]"},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0019","doi-asserted-by":"crossref","unstructured":"van Duin D., Bonomo R.A. Ceftazidime\/Avibactam and Ceftolozane\/Tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations. Saravolatz LD, editor. Clin Infect Dis [Internet]. 2016 Jul 15;63(2):234\u201341. Available from: https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/ciw243.","DOI":"10.1093\/cid\/ciw243"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.117206_bib0020","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/jac\/dkw239","article-title":"Spotlight on ceftazidime\/avibactam: a new option for MDR gram-negative infections","volume":"71","author":"Falcone","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.117206_bib0021","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1128\/AAC.01165-15","article-title":"First report of ceftazidime-avibactam resistance in a KPC-3-expressing Klebsiella pneumoniae isolate","volume":"59","author":"Humphries","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.37201\/req\/s02.01.2022","article-title":"Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives","volume":"35","author":"Garcia-Bustos","year":"2022","journal-title":"Rev Esp Quim"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2025.117206_bib0023","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1093\/cid\/ciaa1478","article-title":"Infectious Diseases Society of America guidance on the treatment of extended-spectrum \u03b2-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR- P. AER","volume":"72","author":"Tamma","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.117206_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00846-21","article-title":"Evaluation of susceptibility testing methods for aztreonam and ceftazidime-avibactam combination therapy on extensively drug-resistant gram-negative organisms","volume":"65","author":"Khan","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jgar.2022.01.025","article-title":"A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi metallo-beta-lactamase (NDM)\u2013producing Enterobacterales infection","volume":"29","author":"Rawson","year":"2022","journal-title":"J Glob Antimicrob Resist [Internet]"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.117206_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jcm.01647-22","article-title":"Multicenter evaluation of an MIC-based Aztreonam and Ceftazidime-avibactam broth disk elution test","volume":"61","author":"Harris","year":"2023","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0027","series-title":"CLSI M100TM performance standards for antimicrobial susceptibility testing","year":"2024"},{"issue":"March","key":"10.1016\/j.diagmicrobio.2025.117206_bib0028","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2147\/IDR.S402275","article-title":"A simple disk stacking plus micro-elution method for rapid detection of the synergistic effect of Aztreonam and Ceftazidime\/Avibactam against metallo-\u03b2-lactamase producing enterobacterales","volume":"16","author":"Liu","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"January","key":"10.1016\/j.diagmicrobio.2025.117206_bib0029","article-title":"Indian Journal of Medical Microbiology rapid characterization of carbapenem-resistant enterobacterales by multiplex lateral flow assay and detection of ceftazidime-avibactam-aztreonam synergy","volume":"47","author":"Kalaivani","year":"2024","journal-title":"Indian J Med Microbiol [Internet]"},{"issue":"5 May","key":"10.1016\/j.diagmicrobio.2025.117206_bib0030","first-page":"1","article-title":"Evaluation of a simple method for testing aztreonam and ceftazidime-avibactam synergy in New Delhi metallo-beta-lactamase producing enterobacterales","volume":"19","author":"Khan","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0031","unstructured":"Borgohain A., Kg R. In vitro effect of ceftazidime-Avibactam by synergy testing with Aztreonam using disc E strip method - contribution of promising combination in the era of antibiotic resistance. 2024;16(6):1249\u201355."},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0032","series-title":"District laboratory practice in tropical countries","first-page":"1","author":"Cheesbrough","year":"2006"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0033","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21608\/ejmm.2023.277771","article-title":"Assessment of phenotypic testing by mCIM with eCIM for determination of the type of carbapenemase produced by carbapenem-resistant enterobacterales","volume":"32","author":"Aboulela","year":"2023","journal-title":"Egypt J Med Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.117206_bib0034","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/jcm.29.3.533-538.1991","article-title":"Comparison of the E test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria","volume":"29","author":"Baker","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.117206_bib0035","unstructured":"Indian Council of Medical Research. Guidance on diagnosis & management of carbapenem resistant gram-negative infections. 2022;1\u201324."},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0036","first-page":"1","article-title":"Ceftazidime-avibactam plus aztreonam synergistic combination tested against carbapenem-resistant enterobacterales characterized phenotypically and genotypically: a glimmer of hope","volume":"22","author":"Taha","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"March","key":"10.1016\/j.diagmicrobio.2025.117206_bib0037","first-page":"1","article-title":"Global threat of carbapenem-resistant gram-negative bacteria","volume":"12","author":"Jean","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.117206_bib0038","first-page":"150","article-title":"Prevalence and molecular characterization of carbapenem resistant gram-negative bacilli in a tertiary care hospital in Mumbai","volume":"9","author":"Prabhala","year":"2023","journal-title":"IP Int J Med Microbiol Trop Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.117206_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofad649","article-title":"The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and meta-analysis","volume":"11","author":"Lin","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-022-01197-6","article-title":"Antibiotic resistance pattern of microorganisms causing urinary tract infection: a 10-year comparative analysis in a tertiary care hospital of Bangladesh","volume":"11","author":"Majumder","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"issue":"November","key":"10.1016\/j.diagmicrobio.2025.117206_bib0041","first-page":"1","article-title":"In vitro activity comparison of ceftazidime\u2013Avibactam and aztreonam\u2013Avibactam against bloodstream infections with carbapenem-resistant organisms in China","volume":"11","author":"Yu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0042","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3329\/bjm.v40i1.71687","article-title":"Multidrug resistance pattern of Pseudomonas aeruginosa isolated from patients with nosocomial infection","volume":"40","author":"Saha","year":"2024","journal-title":"Bangladesh J Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.117206_bib0043","first-page":"11","article-title":"Detection of carbapenemase production by modified carbapenem inactivation method among carbapenem resistant gram- negative Bacilli at a Tertiary Care Centre in Coimbatore, Tamil Nadu, India","volume":"12","author":"Baskaran","year":"2023","journal-title":"Natl J Lab Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117206_bib0044","first-page":"134","article-title":"Detection of metallo beta-lactamase (MBL) producing Pseudomonas aeruginosa in a Tertiary Care Hospital, Ghanpur, Medchal, India","volume":"17","author":"Radhika","year":"2022","journal-title":"Maedica (Buchar) [Internet]"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2025.117206_bib0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.22159\/ajpcr.2023.v16i8.47629","article-title":"Detection of carbapenemase-producing carbapenem-resistant in blood culture isolates by Mcim and Ecim and its susceptibility to tigecycline and minocycline","volume":"16","author":"Kachari","year":"2023","journal-title":"Asian J Pharm Clin Res"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2025.117206_bib0046","doi-asserted-by":"crossref","first-page":"79","DOI":"10.71152\/ajms.v15i8.858","article-title":"Phenotypic detection of carbapenem-resistant enterobacterales and carbapenem-resistant Pseudomonas aeruginosa by mCIM and eCIM and their ceftazidime-avibactam with aztreonam synergy profile in a tertiary care hospital in Eastern India","volume":"15","author":"Chanda","year":"2024","journal-title":"Asian J Med Sci"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.117206_bib0047","first-page":"4","article-title":"Modified carbapenem inactivation method and ethylenediaminetetraacetic acid (EDTA)-carbapenem inactivation method for detection of carbapenemase-producing enterobacterales and Pseudomonas aeruginosa","volume":"16","author":"Verma","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.117206_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01814-18","article-title":"In vitro activity of Ceftazidime-Avibactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa collected in Latin American countries: results from the INFORM global surveillance program, 2012 to 2015","volume":"63","author":"Karlowsky","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2025.117206_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00472-17","article-title":"In vitro activity of aztreonam-avibactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated by clinical laboratories in 40 countries from 2012 to 2015","volume":"61","author":"Karlowsky","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.117206_bib0050","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"APR","key":"10.1016\/j.diagmicrobio.2025.117206_bib0051","first-page":"1","article-title":"Pseudomonas aeruginosa: resistance to the max","volume":"2","author":"Poole","year":"2011","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.117206_bib0052","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/cid\/ciaa586","article-title":"Efficacy of Ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase-producing enterobacterales","volume":"72","author":"Falcone","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.117206_bib0053","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1128\/aac.00751-22","article-title":"Ceftazidime-avibactam plus aztreonam for the treatment of infections by VIM-type-producing gram-negative bacteria","volume":"66","author":"Sempere","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.117206_bib0054","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/jac\/dkad061","article-title":"In vitro activity of cefepime\/zidebactam and cefepime\/taniborbactam against aztreonam\/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates","volume":"78","author":"Le Terrier","year":"2023","journal-title":"J Antimicrob Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325005280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325005280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:34:35Z","timestamp":1770910475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325005280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0732889325005280"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117206","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effect of ceftazidime-avibactam and aztreonam combination against carbapenem resistant Klebsiella spp., E.coli and Pseudomonas spp","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117206"}}